Rockefeller Capital Management
KURA icon

Rockefeller Capital Management’s Kura Oncology KURA Stock Holding History

Rockefeller Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2K Buy
1,500
+904
+152% +$7.77K ﹤0.01% 3909
2025
Q4 		$6.19K Buy
+596
New +$6.25K ﹤0.01% 3999
2023
Q1 		– Sell
-26
Closed – – 3028
2022
Q4 		$0 Sell
26
-111
-81% -$1.61K ﹤0.01% 4051
2022
Q3 		$1K Sell
137
-336
-71% -$5.18K ﹤0.01% 3742
2022
Q2 		$8K Buy
473
+447
+1,719% +$6.43K ﹤0.01% 3235
2022
Q1 		$0 Hold
26
– – ﹤0.01% 3978
2021
Q4 		$0 Buy
+26
New +$421 ﹤0.01% 3886
2021
Q3 		– Sell
-29
Closed – – 3765
2021
Q2 		$0 Buy
+29
New +$720 ﹤0.01% 3524

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rockefeller Capital Management's KURA Position: Q1 2026 in Review

Rockefeller Capital Management increased its Kura Oncology (KURA) stake by 152% in Q1 2026, buying an estimated $7.77K and bringing the position to 1,500 shares worth $12.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3909.

Rockefeller Capital Management first reported a position in KURA in Q2 2021 and has held it in 8 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Rockefeller Capital Management held 1,500 shares of Kura Oncology worth $12.2K as of Q1 2026.
  • Rockefeller Capital Management bought 904 Kura Oncology shares in Q1 2026, an estimated $7.77K.
  • Kura Oncology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3909 holding.
  • Rockefeller Capital Management first reported a position in Kura Oncology in Q2 2021 and has held it in 8 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.